Navigation Links
OmniGuide(R) Secures $25 Million in Funding to Support Continued Growth and New Market Penetration
Date:5/15/2008

CAMBRIDGE, Mass., May 15 /PRNewswire/ -- OmniGuide, Inc., the developer of the first and only flexible CO2 laser scalpel enabling new procedures in minimally invasive surgery, today announced the closing of a $25 million series E private equity round. Psilos Group, a healthcare venture capital and private equity firm, led the funding round which includes previous OmniGuide investors: Ray Stata, Stata Venture Partners, 3i, Argonaut Ventures, ESI, Gainesborough Investments, Jeff Swartz and Westbury Partners. Thomas Weisel Partners served as advisor and placement agent for OmniGuide.

OmniGuide's BeamPath(TM) CO2 laser fibers are the most precise optical scalpels available. Since commercially launching in late-2006, OmniGuide optical scalpels have been rapidly adopted for use in minimally invasive surgeries in the U.S. and recently in Europe. To date, OmniGuide scalpels have been used successfully in more than 3,000 surgeries for treatment of head and neck cancers, for removal of life-threatening airway papillomas in adults and children, and for hearing restoration surgeries. OmniGuide distributes its disposable scalpels through a nationwide direct sales group.

"CO2 laser light offers unique precision, safety and cost benefits to minimally invasive surgeries. Our fibers deliver, for the first time, this medically advantageous light to areas in the body that could not have been reached previously," said Yoel Fink, president and CEO of OmniGuide. "OmniGuide's BeamPath fibers are enabling superior healthcare in more than 200 hospitals nationwide and are now available in Europe. Today's investment will help fuel OmniGuide's expansion into additional clinical markets such as otology, spinal surgery, neurosurgery, gastroenterology and gynecology."

"OmniGuide is an extremely promising medical device company and we believe that the value created by its products is highly aligned with our firm's investment philosophy," said Lisa M. Suennen, co-founder and managing member at Psilos Group. "Specifically, the BeamPath fiber offers the ability to undertake such precise, tissue-sparing, minimally invasive surgery which may result in significantly reduced complications and morbidity for patients, a considerably enhanced physician experience, and potentially dramatic cost reductions and outcome improvements for a wide array of surgical procedures. This matches well with our desire to back companies that truly align the incentives of patients, payers and providers to the benefit of the overall healthcare system. We are very excited to support the company's already significant growth and excellent management team with our investment."

"We are pleased to have Psilos Group join our investing partners to help further accelerate our momentum as OmniGuide transforms into a global healthcare company," said Ray Stata, chairman of the board.

About BeamPath Precision Optical Scalpels

Surgeons have used CO2 lasers for more than 30 years due to the high-degree of precision cutting capabilities. However, the lasers were previously limited to "line-of-sight" procedures with no flexible delivery available. OmniGuide's BeamPath fiber is based on breakthrough fiber technology developed at MIT, first published in Nature and exclusively licensed to OmniGuide. This technology has enabled OmniGuide to manufacture the world's first flexible fibers for CO2 laser surgery. BeamPath fibers empower surgeons to perform delicate cutting and coagulation with minimal thermal tissue damage and ultimate maneuverability, a major advantage over traditional line-of-sight CO2 lasers. To date, BeamPath fibers have been used successfully in more than 3,000 surgical procedures.

About Psilos Group

Psilos Group has been a successful healthcare venture capital and private equity firm since its founding in 1998. With over $575M under management, Psilos focuses its investments across the healthcare services, healthcare information technology, and medical technology sectors. Psilos invests nationwide in businesses that are poised to create enduring market value by fundamentally improving the U.S. healthcare system. Psilos' portfolio companies are sustainable and high-value businesses that have a demonstrated ability to reduce the costs of healthcare delivery, improve clinical quality and advance the alignment of payer, patient and provider incentives. Psilos has offices in New York, the San Francisco Bay Area and Santa Fe, New Mexico.

About OmniGuide, Inc.

OmniGuide, Inc., is the worldwide leader in precision optical scalpels for minimally invasive surgery. OmniGuide CO2 laser fiber products are clinically targeted disposable optical scalpels optimized for specific surgical procedures. The company has recently introduced a line of fiber-enabled, portable, low-cost CO2 lasers for use in operating rooms and surgical suites. The company designs and manufactures its fiber products in Cambridge, Mass. based on multi-material photonic bandgap fiber technology exclusively licensed from MIT. The company distributes its products in the U.S. and Europe through a direct sales force. OmniGuide is committed to developing products that improve and expand surgical treatment options, enhance clinical outcomes, and reduce treatment complexity and cost.
Additional information about OmniGuide may be found at http://www.omni-guide.com

Contacts: Dana Conti or Lori Stein

Schwartz Communications

(781) 684-0770

OmniGuide@schwartz-pr.com


'/>"/>
SOURCE OmniGuide, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lisa M. Suennen Joins OmniGuide(R) Board of Directors
2. Asoyia Secures Venture Capital Funding
3. InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group
4. SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
5. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
6. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
7. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
8. Piedmont Pharmaceuticals Secures $8.5 Million Investment
9. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
10. UI licensee Optherion secures $37 million in financing
11. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses ... human interest stories, courtesy of leaders in the nursing and health care industry. ... from leading advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett ...
(Date:5/27/2016)... ... ... With a team of certified experts, Validation Center is ... GMP accreditation, Validation Center is also a registered authority of the international system ... Validation Center is ISO17025 accredited and only offers its clients the latest technology, ...
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ., the maker ... 2016 When Work Works Award for its use of effective workplace strategies to increase ... Works project administered by the Families and Work Institute (FWI) and the Society for ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... property (IP) to its specialty academic programs. , Answering to the increasing demand ... certificate programs in health law, and environmental and land use law. ,  , ...
(Date:5/26/2016)... ... , ... The Woodlands at John Knox Village , Florida’s first Life ... living and healing, celebrated its grand opening, today. The Woodlands at John Knox Village ... Empowered Staff. , “This is an incredibly fulfilling time for John Knox Village as ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 ... Market by Type (3D, 2D, 4D), by Therapeutic Area ... by End User (Medical Device Manufacturers, Hospitals/ Clinics) - ... the global Medical Animation Market for the forecast period ... reach USD 301.3 Million by 2021 from USD 117.3 ...
(Date:5/25/2016)...  Zymo Research Corp. announced today the final ... that help researchers obtain the most accurate and ... rapid growth of the study of microbiomes has ... methods to improve the reproducibility and quality of ... every step of the measurement process including collection ...
(Date:5/25/2016)... 2016 As illustrated by the ... month, the numbers and momentum of cannabis in the ... the billions, more research and development push the sector ... of Legal Marijuana Markets Report  from from ArcView Market ... of the increase in sector is attributed to adult ...
Breaking Medicine Technology: